Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

The past year for Creo Medical (LON:CREO) investors has not been profitable

Taking the occasional loss comes part and parcel with investing on the stock market. And unfortunately for Creo Medical Limited (LON:CREO) shareholders, the stock is a lot lower today than it was a year ago. The share price is down a hefty 54% in …

EODHD | 19 July 2022

Vicon launches new Valkyrie solution

19 July 2022 Oxford Metrics plc ("Oxford Metrics or the “Group”) Vicon launches new Valkyrie solution Vicon’s most advanced range ever will drive forward new ground-breaking motion capture applications Oxford Metrics plc (LSE: OMG), the smart sensing software company, servicing life sciences, entertainment and …

EODHD | 19 July 2022

Is Lok'nStore Group Plc's (LON:LOK) Recent Price Movement Underpinned By Its Weak Fundamentals?

With its stock down 11% over the past three months, it is easy to disregard Lok'nStore Group (LON:LOK). We, however decided to study the company's financials to determine if they have got anything to do with the price decline. Long-term fundamentals are usually what …

EODHD | 19 July 2022

Could The Market Be Wrong About BATM Advanced Communications Ltd. (LON:BVC) Given Its Attractive Financial Prospects?

BATM Advanced Communications (LON:BVC) has had a rough three months with its share price down 32%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. …

EODHD | 19 July 2022

Investors in Fleetwood (ASX:FWD) have unfortunately lost 23% over the last five years

Fleetwood Limited (ASX:FWD) shareholders should be happy to see the share price up 11% in the last month. But that doesn't change the fact that the returns over the last five years have been less than pleasing. You would have done a lot better …

EODHD | 18 July 2022

The past year for Pentanet (ASX:5GG) investors has not been profitable

Pentanet Limited (ASX:5GG) shareholders should be happy to see the share price up 21% in the last month. But that is minimal compensation for the share price under-performance over the last year. In fact, the price has declined 46% in a year, falling short …

EODHD | 18 July 2022

Is GWA Group Limited's (ASX:GWA) Stock Price Struggling As A Result Of Its Mixed Financials?

GWA Group (ASX:GWA) has had a rough three months with its share price down 15%. It seems that the market might have completely ignored the positive aspects of the company's fundamentals and decided to weigh-in more on the negative aspects. Long-term fundamentals are usually …

EODHD | 18 July 2022

The Power Play by The Market Herald Releases New Interviews with First Mining Gold Corp., Algernon Pharmaceuticals, G Mining Ventures, ApartmentLove, and Orvana Minerals

VANCOUVER, BC / ACCESSWIRE / July 18, 2022 / The Power Play by The Market Herald has announced the release of new interviews with First Mining Gold Corp., Algernon Pharmaceuticals, G Mining Ventures, ApartmentLove, and Orvana Minerals on their latest news. The Power Play …

EODHD | 18 July 2022

BioPharma Credit PLC's (LON:BPCR) Popularity With Investors Is Under Threat From Overpricing

With a median price-to-earnings (or "P/E") ratio of close to 14x in the United Kingdom, you could be forgiven for feeling indifferent about BioPharma Credit PLC's (LON:BPCR) P/E ratio of 15.2x. Although, it's not wise to simply ignore the P/E without explanation as investors …

EODHD | 18 July 2022

Plato Income Maximiser (ASX:PL8) Has Announced A Dividend Of A$0.0055

Plato Income Maximiser Limited (ASX:PL8) has announced that it will pay a dividend of A$0.0055 per share on the 29th of July. This makes the dividend yield 5.6%, which will augment investor returns quite nicely. See our latest analysis for Plato Income Maximiser Plato …

EODHD | 18 July 2022

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions